The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CDMO for Transdermal Patches and Oral Film Market Research Report 2025
Synopsis
CDMO stands for Contract Development and Manufacturing Organization. In the context of transdermal patches and oral films, a CDMO specializing in these dosage forms would offer services such as formulation development, process optimization, scale-up, manufacturing, packaging, and regulatory support for pharmaceutical companies looking to outsource these aspects of their product development. These CDMOs have expertise in developing and manufacturing transdermal patches and oral films, ensuring that they meet quality standards and regulatory requirements.
The global CDMO for Transdermal Patches and Oral Film market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market trend for Contract Development and Manufacturing Organizations (CDMO) in the transdermal patches and oral film industry is showing significant growth, with major sales regions including North America, Europe, and Asia Pacific. The market concentration is high, with a few key players dominating the industry and offering a wide range of services such as formulation development, analytical testing, and regulatory support. There are ample market opportunities for CDMOs in this sector, as the demand for innovative drug delivery systems continues to rise, driven by factors such as the increasing prevalence of chronic diseases and the need for convenient and patient-friendly dosage forms. However, there are also challenges to be aware of, such as regulatory hurdles, pricing pressures, and the need for continuous innovation to stay competitive in the market. Overall, the outlook for CDMOs in the transdermal patches and oral film market is positive, with strong growth potential and opportunities for expansion in both established and emerging markets.
This report aims to provide a comprehensive presentation of the global market for CDMO for Transdermal Patches and Oral Film, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CDMO for Transdermal Patches and Oral Film.
Report Scope
The CDMO for Transdermal Patches and Oral Film market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CDMO for Transdermal Patches and Oral Film market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CDMO for Transdermal Patches and Oral Film companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AdhexPharma
Nissha
Tapemark
tesa
LTS Lohmann
IntelGenx
MedPharm
Adhesives Research
Shilpa Medicare Limited
ROFARMA
Kindeva Drug Delivery
ProSolus
Altergon
Youwei Biotech
Segment by Type
Transdermal Patches
Oral Film
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CDMO for Transdermal Patches and Oral Film companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CDMO stands for Contract Development and Manufacturing Organization. In the context of transdermal patches and oral films, a CDMO specializing in these dosage forms would offer services such as formulation development, process optimization, scale-up, manufacturing, packaging, and regulatory support for pharmaceutical companies looking to outsource these aspects of their product development. These CDMOs have expertise in developing and manufacturing transdermal patches and oral films, ensuring that they meet quality standards and regulatory requirements.
The global CDMO for Transdermal Patches and Oral Film market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market trend for Contract Development and Manufacturing Organizations (CDMO) in the transdermal patches and oral film industry is showing significant growth, with major sales regions including North America, Europe, and Asia Pacific. The market concentration is high, with a few key players dominating the industry and offering a wide range of services such as formulation development, analytical testing, and regulatory support. There are ample market opportunities for CDMOs in this sector, as the demand for innovative drug delivery systems continues to rise, driven by factors such as the increasing prevalence of chronic diseases and the need for convenient and patient-friendly dosage forms. However, there are also challenges to be aware of, such as regulatory hurdles, pricing pressures, and the need for continuous innovation to stay competitive in the market. Overall, the outlook for CDMOs in the transdermal patches and oral film market is positive, with strong growth potential and opportunities for expansion in both established and emerging markets.
This report aims to provide a comprehensive presentation of the global market for CDMO for Transdermal Patches and Oral Film, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CDMO for Transdermal Patches and Oral Film.
Report Scope
The CDMO for Transdermal Patches and Oral Film market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CDMO for Transdermal Patches and Oral Film market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CDMO for Transdermal Patches and Oral Film companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AdhexPharma
Nissha
Tapemark
tesa
LTS Lohmann
IntelGenx
MedPharm
Adhesives Research
Shilpa Medicare Limited
ROFARMA
Kindeva Drug Delivery
ProSolus
Altergon
Youwei Biotech
Segment by Type
Transdermal Patches
Oral Film
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CDMO for Transdermal Patches and Oral Film companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Transdermal Patches
1.2.3 Oral Film
1.3 Market by Application
1.3.1 Global CDMO for Transdermal Patches and Oral Film Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CDMO for Transdermal Patches and Oral Film Market Perspective (2019-2030)
2.2 CDMO for Transdermal Patches and Oral Film Growth Trends by Region
2.2.1 Global CDMO for Transdermal Patches and Oral Film Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CDMO for Transdermal Patches and Oral Film Historic Market Size by Region (2019-2024)
2.2.3 CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Region (2025-2030)
2.3 CDMO for Transdermal Patches and Oral Film Market Dynamics
2.3.1 CDMO for Transdermal Patches and Oral Film Industry Trends
2.3.2 CDMO for Transdermal Patches and Oral Film Market Drivers
2.3.3 CDMO for Transdermal Patches and Oral Film Market Challenges
2.3.4 CDMO for Transdermal Patches and Oral Film Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CDMO for Transdermal Patches and Oral Film Players by Revenue
3.1.1 Global Top CDMO for Transdermal Patches and Oral Film Players by Revenue (2019-2024)
3.1.2 Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Players (2019-2024)
3.2 Global CDMO for Transdermal Patches and Oral Film Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CDMO for Transdermal Patches and Oral Film Revenue
3.4 Global CDMO for Transdermal Patches and Oral Film Market Concentration Ratio
3.4.1 Global CDMO for Transdermal Patches and Oral Film Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CDMO for Transdermal Patches and Oral Film Revenue in 2023
3.5 CDMO for Transdermal Patches and Oral Film Key Players Head office and Area Served
3.6 Key Players CDMO for Transdermal Patches and Oral Film Product Solution and Service
3.7 Date of Enter into CDMO for Transdermal Patches and Oral Film Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CDMO for Transdermal Patches and Oral Film Breakdown Data by Type
4.1 Global CDMO for Transdermal Patches and Oral Film Historic Market Size by Type (2019-2024)
4.2 Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Type (2025-2030)
5 CDMO for Transdermal Patches and Oral Film Breakdown Data by Application
5.1 Global CDMO for Transdermal Patches and Oral Film Historic Market Size by Application (2019-2024)
5.2 Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
6.2 North America CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024)
6.4 North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
7.2 Europe CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024)
7.4 Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
8.2 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2024)
8.4 Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
9.2 Latin America CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024)
9.4 Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
10.2 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024)
10.4 Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AdhexPharma
11.1.1 AdhexPharma Company Detail
11.1.2 AdhexPharma Business Overview
11.1.3 AdhexPharma CDMO for Transdermal Patches and Oral Film Introduction
11.1.4 AdhexPharma Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.1.5 AdhexPharma Recent Development
11.2 Nissha
11.2.1 Nissha Company Detail
11.2.2 Nissha Business Overview
11.2.3 Nissha CDMO for Transdermal Patches and Oral Film Introduction
11.2.4 Nissha Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.2.5 Nissha Recent Development
11.3 Tapemark
11.3.1 Tapemark Company Detail
11.3.2 Tapemark Business Overview
11.3.3 Tapemark CDMO for Transdermal Patches and Oral Film Introduction
11.3.4 Tapemark Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.3.5 Tapemark Recent Development
11.4 tesa
11.4.1 tesa Company Detail
11.4.2 tesa Business Overview
11.4.3 tesa CDMO for Transdermal Patches and Oral Film Introduction
11.4.4 tesa Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.4.5 tesa Recent Development
11.5 LTS Lohmann
11.5.1 LTS Lohmann Company Detail
11.5.2 LTS Lohmann Business Overview
11.5.3 LTS Lohmann CDMO for Transdermal Patches and Oral Film Introduction
11.5.4 LTS Lohmann Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.5.5 LTS Lohmann Recent Development
11.6 IntelGenx
11.6.1 IntelGenx Company Detail
11.6.2 IntelGenx Business Overview
11.6.3 IntelGenx CDMO for Transdermal Patches and Oral Film Introduction
11.6.4 IntelGenx Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.6.5 IntelGenx Recent Development
11.7 MedPharm
11.7.1 MedPharm Company Detail
11.7.2 MedPharm Business Overview
11.7.3 MedPharm CDMO for Transdermal Patches and Oral Film Introduction
11.7.4 MedPharm Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.7.5 MedPharm Recent Development
11.8 Adhesives Research
11.8.1 Adhesives Research Company Detail
11.8.2 Adhesives Research Business Overview
11.8.3 Adhesives Research CDMO for Transdermal Patches and Oral Film Introduction
11.8.4 Adhesives Research Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.8.5 Adhesives Research Recent Development
11.9 Shilpa Medicare Limited
11.9.1 Shilpa Medicare Limited Company Detail
11.9.2 Shilpa Medicare Limited Business Overview
11.9.3 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Introduction
11.9.4 Shilpa Medicare Limited Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.9.5 Shilpa Medicare Limited Recent Development
11.10 ROFARMA
11.10.1 ROFARMA Company Detail
11.10.2 ROFARMA Business Overview
11.10.3 ROFARMA CDMO for Transdermal Patches and Oral Film Introduction
11.10.4 ROFARMA Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.10.5 ROFARMA Recent Development
11.11 Kindeva Drug Delivery
11.11.1 Kindeva Drug Delivery Company Detail
11.11.2 Kindeva Drug Delivery Business Overview
11.11.3 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Introduction
11.11.4 Kindeva Drug Delivery Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.11.5 Kindeva Drug Delivery Recent Development
11.12 ProSolus
11.12.1 ProSolus Company Detail
11.12.2 ProSolus Business Overview
11.12.3 ProSolus CDMO for Transdermal Patches and Oral Film Introduction
11.12.4 ProSolus Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.12.5 ProSolus Recent Development
11.13 Altergon
11.13.1 Altergon Company Detail
11.13.2 Altergon Business Overview
11.13.3 Altergon CDMO for Transdermal Patches and Oral Film Introduction
11.13.4 Altergon Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.13.5 Altergon Recent Development
11.14 Youwei Biotech
11.14.1 Youwei Biotech Company Detail
11.14.2 Youwei Biotech Business Overview
11.14.3 Youwei Biotech CDMO for Transdermal Patches and Oral Film Introduction
11.14.4 Youwei Biotech Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
11.14.5 Youwei Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Transdermal Patches
Table 3. Key Players of Oral Film
Table 4. Global CDMO for Transdermal Patches and Oral Film Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global CDMO for Transdermal Patches and Oral Film Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global CDMO for Transdermal Patches and Oral Film Market Share by Region (2019-2024)
Table 8. Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global CDMO for Transdermal Patches and Oral Film Market Share by Region (2025-2030)
Table 10. CDMO for Transdermal Patches and Oral Film Market Trends
Table 11. CDMO for Transdermal Patches and Oral Film Market Drivers
Table 12. CDMO for Transdermal Patches and Oral Film Market Challenges
Table 13. CDMO for Transdermal Patches and Oral Film Market Restraints
Table 14. Global CDMO for Transdermal Patches and Oral Film Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global CDMO for Transdermal Patches and Oral Film Market Share by Players (2019-2024)
Table 16. Global Top CDMO for Transdermal Patches and Oral Film Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CDMO for Transdermal Patches and Oral Film as of 2023)
Table 17. Ranking of Global Top CDMO for Transdermal Patches and Oral Film Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by CDMO for Transdermal Patches and Oral Film Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CDMO for Transdermal Patches and Oral Film Product Solution and Service
Table 21. Date of Enter into CDMO for Transdermal Patches and Oral Film Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Type (2019-2024)
Table 25. Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Type (2025-2030)
Table 27. Global CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Application (2019-2024)
Table 29. Global CDMO for Transdermal Patches and Oral Film Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global CDMO for Transdermal Patches and Oral Film Revenue Market Share by Application (2025-2030)
Table 31. North America CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size by Country (2025-2030) & (US$ Million)
Table 46. AdhexPharma Company Detail
Table 47. AdhexPharma Business Overview
Table 48. AdhexPharma CDMO for Transdermal Patches and Oral Film Product
Table 49. AdhexPharma Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 50. AdhexPharma Recent Development
Table 51. Nissha Company Detail
Table 52. Nissha Business Overview
Table 53. Nissha CDMO for Transdermal Patches and Oral Film Product
Table 54. Nissha Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 55. Nissha Recent Development
Table 56. Tapemark Company Detail
Table 57. Tapemark Business Overview
Table 58. Tapemark CDMO for Transdermal Patches and Oral Film Product
Table 59. Tapemark Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 60. Tapemark Recent Development
Table 61. tesa Company Detail
Table 62. tesa Business Overview
Table 63. tesa CDMO for Transdermal Patches and Oral Film Product
Table 64. tesa Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 65. tesa Recent Development
Table 66. LTS Lohmann Company Detail
Table 67. LTS Lohmann Business Overview
Table 68. LTS Lohmann CDMO for Transdermal Patches and Oral Film Product
Table 69. LTS Lohmann Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 70. LTS Lohmann Recent Development
Table 71. IntelGenx Company Detail
Table 72. IntelGenx Business Overview
Table 73. IntelGenx CDMO for Transdermal Patches and Oral Film Product
Table 74. IntelGenx Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 75. IntelGenx Recent Development
Table 76. MedPharm Company Detail
Table 77. MedPharm Business Overview
Table 78. MedPharm CDMO for Transdermal Patches and Oral Film Product
Table 79. MedPharm Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 80. MedPharm Recent Development
Table 81. Adhesives Research Company Detail
Table 82. Adhesives Research Business Overview
Table 83. Adhesives Research CDMO for Transdermal Patches and Oral Film Product
Table 84. Adhesives Research Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 85. Adhesives Research Recent Development
Table 86. Shilpa Medicare Limited Company Detail
Table 87. Shilpa Medicare Limited Business Overview
Table 88. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product
Table 89. Shilpa Medicare Limited Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 90. Shilpa Medicare Limited Recent Development
Table 91. ROFARMA Company Detail
Table 92. ROFARMA Business Overview
Table 93. ROFARMA CDMO for Transdermal Patches and Oral Film Product
Table 94. ROFARMA Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 95. ROFARMA Recent Development
Table 96. Kindeva Drug Delivery Company Detail
Table 97. Kindeva Drug Delivery Business Overview
Table 98. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product
Table 99. Kindeva Drug Delivery Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 100. Kindeva Drug Delivery Recent Development
Table 101. ProSolus Company Detail
Table 102. ProSolus Business Overview
Table 103. ProSolus CDMO for Transdermal Patches and Oral Film Product
Table 104. ProSolus Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 105. ProSolus Recent Development
Table 106. Altergon Company Detail
Table 107. Altergon Business Overview
Table 108. Altergon CDMO for Transdermal Patches and Oral Film Product
Table 109. Altergon Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 110. Altergon Recent Development
Table 111. Youwei Biotech Company Detail
Table 112. Youwei Biotech Business Overview
Table 113. Youwei Biotech CDMO for Transdermal Patches and Oral Film Product
Table 114. Youwei Biotech Revenue in CDMO for Transdermal Patches and Oral Film Business (2019-2024) & (US$ Million)
Table 115. Youwei Biotech Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CDMO for Transdermal Patches and Oral Film Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CDMO for Transdermal Patches and Oral Film Market Share by Type: 2023 VS 2030
Figure 3. Transdermal Patches Features
Figure 4. Oral Film Features
Figure 5. Global CDMO for Transdermal Patches and Oral Film Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global CDMO for Transdermal Patches and Oral Film Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Company Case Studies
Figure 8. Biotechnology Company Case Studies
Figure 9. Generic Company Case Studies
Figure 10. CDMO for Transdermal Patches and Oral Film Report Years Considered
Figure 11. Global CDMO for Transdermal Patches and Oral Film Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global CDMO for Transdermal Patches and Oral Film Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global CDMO for Transdermal Patches and Oral Film Market Share by Region: 2023 VS 2030
Figure 14. Global CDMO for Transdermal Patches and Oral Film Market Share by Players in 2023
Figure 15. Global Top CDMO for Transdermal Patches and Oral Film Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CDMO for Transdermal Patches and Oral Film as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by CDMO for Transdermal Patches and Oral Film Revenue in 2023
Figure 17. North America CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America CDMO for Transdermal Patches and Oral Film Market Share by Country (2019-2030)
Figure 19. United States CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe CDMO for Transdermal Patches and Oral Film Market Share by Country (2019-2030)
Figure 23. Germany CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific CDMO for Transdermal Patches and Oral Film Market Share by Region (2019-2030)
Figure 31. China CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America CDMO for Transdermal Patches and Oral Film Market Share by Country (2019-2030)
Figure 39. Mexico CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa CDMO for Transdermal Patches and Oral Film Market Share by Country (2019-2030)
Figure 43. Turkey CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia CDMO for Transdermal Patches and Oral Film Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. AdhexPharma Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 46. Nissha Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 47. Tapemark Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 48. tesa Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 49. LTS Lohmann Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 50. IntelGenx Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 51. MedPharm Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 52. Adhesives Research Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 53. Shilpa Medicare Limited Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 54. ROFARMA Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 55. Kindeva Drug Delivery Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 56. ProSolus Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 57. Altergon Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 58. Youwei Biotech Revenue Growth Rate in CDMO for Transdermal Patches and Oral Film Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
